MedTrace Logo

Emergence of Chemotherapy Related Hyperglycemia in nOn-diabetic Patients

NCT03062072 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 300

Last updated 2017-04-07

No results posted yet for this study

Summary

To assess chemotherapy related hyperglycemia in non-diabetic patients, the investigators will assess the incidence of hyperglycemia and analyze co-medications and risk factors.

Conditions

Interventions

DRUG

Chemotherapy

Chemotherapy containing glucocorticoid as anti-emetics or anti-cancer agent except for targeted agents

Sponsors & Collaborators

  • SMG-SNU Boramae Medical Center

    collaborator OTHER

  • National Cancer Center, Korea

    lead OTHER_GOV

Principal Investigators

  • Eun Kyung Lee · National Cancer Center, Korea

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-04-30
Primary Completion
2017-12-31
Completion
2022-12-31

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03062072 on ClinicalTrials.gov